Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serine-linked PARP1 auto-modification controls PARP inhibitor response
Evgeniia Prokhorova, Florian Zobel, Rebecca Smith, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

The expanding universe of PARP1-mediated molecular and therapeutic mechanisms
Dan Huang, W. Lee Kraus
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2315-2334
Open Access | Times Cited: 158
Molecular Mechanisms of Parthanatos and Its Role in Diverse Diseases
Ping Huang, Guangwei Chen, Weifeng Jin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7292-7292
Open Access | Times Cited: 86
Inhibitors of PARP: Number crunching and structure gazing
Johannes Rudolph, Karen Jung, Karolin Luger
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 11
Open Access | Times Cited: 83
ADP-ribosylation from molecular mechanisms to therapeutic implications
Marcin J. Suskiewicz, Evgeniia Prokhorova, J.G.M. Rack, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4475-4495
Open Access | Times Cited: 67
HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage
Rebecca Smith, Siham Zentout, Magdalena B. Rother, et al.
Nature Structural & Molecular Biology (2023) Vol. 30, Iss. 5, pp. 678-691
Open Access | Times Cited: 44
The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome
Ivo A. Hendriks, Sara C. Buch-Larsen, Evgeniia Prokhorova, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 80
HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications
Marie-France Langelier, Ramya Billur, Aleksandr Sverzhinsky, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 56
PARP1: Liaison of Chromatin Remodeling and Transcription
Wen Zong, Yamin Gong, Wenli Sun, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4162-4162
Open Access | Times Cited: 47
Captured snapshots of PARP1 in the active state reveal the mechanics of PARP1 allostery
Élise Rouleau-Turcotte, Dragomir B. Krastev, Stephen J. Pettitt, et al.
Molecular Cell (2022) Vol. 82, Iss. 16, pp. 2939-2951.e5
Open Access | Times Cited: 42
PARP1 proximity proteomics reveals interaction partners at stressed replication forks
Thorsten Mosler, H. Irem Baymaz, Justus F. Gräf, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 20, pp. 11600-11618
Open Access | Times Cited: 41
PARPs and ADP-ribosylation: Deciphering the complexity with molecular tools
Morgan Dasovich, Anthony K. L. Leung
Molecular Cell (2023) Vol. 83, Iss. 10, pp. 1552-1572
Open Access | Times Cited: 33
PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance
Petar-Bogomil Kanev, Aleksandar Atemin, Stoyno Stoynov, et al.
Seminars in Oncology (2023) Vol. 51, Iss. 1-2, pp. 2-18
Open Access | Times Cited: 22
ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification
Élise Rouleau-Turcotte, John M. Pascal
Journal of Biological Chemistry (2023) Vol. 299, Iss. 12, pp. 105397-105397
Open Access | Times Cited: 22
A unified mechanism for PARP inhibitor-induced PARP1 chromatin retention at DNA damage sites in living cells
Petar-Bogomil Kanev, Sylvia Varhoshkova, Irina Georgieva, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114234-114234
Open Access | Times Cited: 10
Serine ADP-ribosylation in Drosophila provides insights into the evolution of reversible ADP-ribosylation signalling
Pietro Fontana, Sara C. Buch-Larsen, Osamu Suyari, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
PAR recognition by PARP1 regulates DNA‐dependent activities and independently stimulates catalytic activity of PARP1
Waghela Deeksha, Suman Abhishek, Eerappa Rajakumara
FEBS Journal (2023) Vol. 290, Iss. 21, pp. 5098-5113
Open Access | Times Cited: 18
PARP trapping is governed by the PARP inhibitor dissociation rate constant
Angelica A. Gopal, Bianca Fernandez, Justin Delano, et al.
Cell chemical biology (2024) Vol. 31, Iss. 7, pp. 1373-1382.e10
Closed Access | Times Cited: 7
The dynamics and regulation of PARP1 and PARP2 in response to DNA damage and during replication
Hanwen Zhang, Shan Zha
DNA repair (2024) Vol. 140, pp. 103690-103690
Closed Access | Times Cited: 6
The potential of PARP inhibitors in targeted cancer therapy and immunotherapy
Jaromir Hunia, Karol Gawalski, Aleksandra Szredzka, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 23
Selective PARP1 inhibitors, PARP1-based dual-target inhibitors, PROTAC PARP1 degraders, and prodrugs of PARP1 inhibitors for cancer therapy
Xiaopeng Peng, Wanyi Pan, Feng Jiang, et al.
Pharmacological Research (2022) Vol. 186, pp. 106529-106529
Closed Access | Times Cited: 22
The recruitment of ACF1 and SMARCA5 to DNA lesions relies on ADP-ribosylation dependent chromatin unfolding
Eva Pinto Jurado, Rebecca Smith, Nicolas Bigot, et al.
Molecular Biology of the Cell (2024) Vol. 35, Iss. 3
Open Access | Times Cited: 4
PARP enzyme de novo synthesis of protein-free poly(ADP-ribose)
Marie-France Langelier, Manija Mirhasan, Karine Gilbert, et al.
Molecular Cell (2024)
Closed Access | Times Cited: 4
Duplexed CeTEAM drug biosensors reveal determinants of PARP inhibitor selectivity in cells
Maria João Pires, Seher Alam, Alen Lovrić, et al.
Journal of Biological Chemistry (2025), pp. 108361-108361
Open Access
PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword
Clifford M. Csizmar, Antoine N. Saliba, Elizabeth M. Swisher, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6385-6385
Open Access | Times Cited: 30
Novel modifications of PARP inhibitor veliparib increase PARP1 binding to DNA breaks
Uday Kiran Velagapudi, Élise Rouleau-Turcotte, Ramya Billur, et al.
Biochemical Journal (2024) Vol. 481, Iss. 6, pp. 437-460
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top